| |
| |
|
| Insider
Information: |
Moch Kenneth I |
| Relationship: |
|
| City: |
Ramsey |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,963,313 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,254 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,963,313 |
|
|
| Total
Value |
$1,254 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 224.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synvista Therapeutics Inc |
SYNI |
CEO, President & Chair... |
2006-07-19 |
2,962,000 |
2006-07-19 |
0 |
Premium* |
|
|
Chimerix Inc |
CMRX |
President and CEO, Dir... |
2014-03-13 |
1,313 |
2013-11-15 |
0 |
Premium* |
|
|
Zynerba Pharmaceuticals, Inc. |
ZYNE |
|
2023-10-10 |
0 |
2021-08-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZYNE |
Zynerba Pharmaceuticals, ... |
|
• • – |
2023-10-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(75,778) |
0 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2023-06-14 |
4 |
S |
$0.35 |
$40 |
D/D |
(115) |
75,778 |
0 |
% |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
47,824 |
75,893 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2022-06-14 |
4 |
S |
$1.01 |
$40 |
D/D |
(40) |
28,069 |
0 |
% |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,109 |
28,109 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CMRX |
Chimerix Inc |
President and CEO |
• • – |
2014-03-13 |
4 |
AS |
$25.00 |
$474,475 |
D/D |
(18,979) |
1,313 |
0 |
- |
|
| CMRX |
Chimerix Inc |
President and CEO |
• • – |
2014-03-13 |
4 |
OE |
$1.57 |
$23,550 |
D/D |
15,000 |
20,292 |
0 |
- |
|
| CMRX |
Chimerix Inc |
President and CEO |
• • – |
2014-02-24 |
4 |
AS |
$20.00 |
$221,440 |
D/D |
(11,072) |
3,979 |
0 |
- |
|
| CMRX |
Chimerix Inc |
President and CEO |
• • – |
2014-02-24 |
4 |
OE |
$1.57 |
$14,243 |
D/D |
9,072 |
15,051 |
0 |
- |
|
| CMRX |
Chimerix Inc |
President and CEO |
• • – |
2014-01-30 |
4 |
OE |
$1.57 |
$1,457 |
D/D |
928 |
6,907 |
0 |
- |
|
| CMRX |
Chimerix Inc |
President and CEO |
• • – |
2014-01-30 |
4 |
AS |
$20.00 |
$18,560 |
D/D |
(928) |
5,979 |
0 |
- |
|
| CMRX |
Chimerix Inc |
President and CEO |
• • – |
2013-11-15 |
4 |
AS |
$15.62 |
$39,041 |
D/D |
(2,500) |
5,979 |
0 |
- |
|
| CMRX |
Chimerix Inc |
President and CEO |
• • – |
2013-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,479 |
8,479 |
0 |
- |
|
| SYNI |
Synvista Therapeutics Inc |
CEO, President & Chairman |
• • – |
2006-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
160,000 |
2,962,000 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
